Importantly, recent studies have found that GPR65 could be used as a key cancer immune checkpoint inhibitor in human tumor microenvironment, which could inhibit the release of inflammatory factors and induced significant up-regulation of tissue repair genes [10, 11]. Here, GPR65 is linked to neoplasm.